InvestorsHub Logo
Followers 34
Posts 3004
Boards Moderated 0
Alias Born 02/27/2016

Re: None

Thursday, 12/02/2021 2:33:02 PM

Thursday, December 02, 2021 2:33:02 PM

Post# of 462345
Great conference. The analyst seemed well prepared.

I liked how Missling came out emphasizing that we are a plattform

Also liked how he said the difference in effect between the wild type and variant let them know that they have the right target. Even though there is only 1 amino acid difference between the 2, it still showed a difference from the full functioning wild type.

Great to hear that he felt our trial could be registrational because we are loaded with biomarkers and Aduhelm set a precedent.

Hopefully we get some coverage from them.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News